<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37965507</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Prevalence and impact of long COVID-19 among patients with diabetes and cardiovascular diseases in Bangladesh.</ArticleTitle><Pagination><StartPage>1222868</StartPage><MedlinePgn>1222868</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1222868</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2023.1222868</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Co-prevalence of long-COVID-19, cardiovascular diseases and diabetes is one of the major health challenges of the pandemic worldwide. Studies on long-COVID-19 and associated health outcomes are absent in Bangladesh. The main aim of this study was to determine the prevalence and impact of long-COVID-19 on preexisting diabetes and cardiovascular diseases (CVD) on health outcomes among patients in Bangladesh.</AbstractText><AbstractText Label="METHODS">We collected data from 3,250 participants in Bangladesh, retrospectively. Multivariable logistic regression model was used to determine the odds ratio between independent and dependent variables. Kaplan-Meier survival curve was used to determine the cumulative survival.</AbstractText><AbstractText Label="RESULTS">COVID-19 was detected among 73.4% (2,385 of 3,250) participants. Acute long-COVID-19 was detected among 28.4% (678 of 2,385) and chronic long-COVID-19 among 71.6% (1,707 of 2,385) patients. CVD and diabetes were found among 32%, and 24% patients, respectively. Mortality rate was 18% (585 of 3,250) among the participants. Co-prevalence of CVD, diabetes and COVID-19 was involved in majority of fatality (95%). Fever (97%), dry cough (87%) and loss of taste and smell (85%) were the most prevalent symptoms. Patients with co-prevalence of CVD, diabetes and COVID-19 had higher risk of fatality (OR: 3.65, 95% CI, 2.79-4.24). Co-prevalence of CVD, diabetes and chronic long-COVID-19 were detected among 11.9% patients.</AbstractText><AbstractText Label="DISCUSSION">Risk of hospitalization and fatality reduced significantly among the vaccinated. This is one of the early studies on long-COVID-19 in Bangladesh.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sharif, Sharif, Khan, Halawani, Alzahrani, Alzahrani, D&#xed;ez, Vargas, Castilla, Parvez and Dey.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Nadim</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jahangirnagar University, Savar, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharif</LastName><ForeName>Nazmul</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Rajshahi University of Engineering &amp; Technology, Rajshahi, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Afsana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Statistics, Jahangirnagar University, Savar, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halawani</LastName><ForeName>Ibrahim F</ForeName><Initials>IF</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Fuad M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzahrani</LastName><ForeName>Khalid J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;ez</LastName><ForeName>Isabel De la Torre</ForeName><Initials>IT</Initials><AffiliationInfo><Affiliation>University of Valladolid, Valladolid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Debora Libertad Ram&#xed;rez</ForeName><Initials>DLR</Initials><AffiliationInfo><Affiliation>Universidad Internacional Iberoamericana, Campeche, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Internacional do Cuanza, Kuito, Angola.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Fundaci&#xf3;n Universitaria Internacional de Colombia, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castilla</LastName><ForeName>Angel Gabriel Kuc</ForeName><Initials>AGK</Initials><AffiliationInfo><Affiliation>Universidad Internacional Iberoamericana, Campeche, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Europea del Atl&#xe1;ntico, Santander, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidad Internacional Iberoamericana, Arecibo, PR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parvez</LastName><ForeName>Anowar Khasru</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jahangirnagar University, Savar, Bangladesh.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Shuvra Kanti</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Jahangirnagar University, Savar, Bangladesh.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Infection. 2022 Feb;50(1):285-286. doi: 10.1007/s15010-021-01696-5</RefSource><PMID Version="1">34519974</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001459" MajorTopicYN="N" Type="Geographic">Bangladesh</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bangladesh</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">comorbidity</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">long-COVID-19</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37965507</ArticleId><ArticleId IdType="pmc">PMC10641795</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2023.1222868</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharif N, Alzahrani KJ, Ahmed SN, Opu RR, Ahmed N, Talukder A, et al. . Protective measures are associated with the reduction of transmission of COVID-19 in Bangladesh: a nationwide cross-sectional study. PLoS ONE. (2021) 16:e0260287. 10.1371/journal.pone.0260287</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260287</ArticleId><ArticleId IdType="pmc">PMC8608304</ArticleId><ArticleId IdType="pubmed">34807962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. (2020) 92:401&#x2013;2. 10.1002/jmv.25678</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25678</ArticleId><ArticleId IdType="pmc">PMC7166628</ArticleId><ArticleId IdType="pubmed">31950516</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Vaccination Dashboard for Bangladesh . Available online at: http://103.247.238.92/webportal/pages/covid19-vaccination-update.php (accessed April 20, 2023).</Citation></Reference><Reference><Citation>Healthmap . Novel Coronavirus (COVID-19). Available online at: https://www.healthmap.org/covid-19/ (accessed April 20, 2023).</Citation></Reference><Reference><Citation>WHO Coronavirus Disease (COVID-19) Dashboard . Available online at: https://covid19.who.int// (accessed April 20, 2023).</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Long COVID: current definition. Infection. (2022) 50:285&#x2013;6. 10.1007/s15010-021-01696-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce JD, Shen Q, Cintron SA, Hiebert JB. Post-COVID-19 syndrome. Nurs Res. (2022) 71:164&#x2013;74. 10.1097/NNR.0000000000000565</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000565</ArticleId><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. . Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. Morb Mortal Wkly Rep. (2022) 71:713. 10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AA, Saad M, Zayan HE, Abdelsayed M, Moustafa M, Ezzat AR, et al. . Post-COVID-19 functional status: relation to age, smoking, hospitalization, and previous comorbidities. Ann Thorac Med. (2021) 16:260. 10.4103/atm.atm_606_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/atm.atm_606_20</ArticleId><ArticleId IdType="pmc">PMC8388571</ArticleId><ArticleId IdType="pubmed">34484441</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Cui Y, Shen M, Zhang J, Liu B, Dai M, et al. . Association of diabetes mellitus with disease severity and prognosis in COVID-19: a retrospective cohort study. Diabetes Res Clin Pract. (2020) 165:108227. 10.1016/j.diabres.2020.108227</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108227</ArticleId><ArticleId IdType="pmc">PMC7242190</ArticleId><ArticleId IdType="pubmed">32446795</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:1494. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. . Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr Clin Res Rev. (2020) 14:535&#x2013;45. 10.1016/j.dsx.2020.04.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.044</ArticleId><ArticleId IdType="pmc">PMC7200339</ArticleId><ArticleId IdType="pubmed">32408118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. . Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. (2020) 109:531&#x2013;38. 10.1007/s00392-020-01626-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. (2020) 5:802&#x2013;10. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Ahmed SN, Opu RR, Tani MR, Dewan D, Daullah MU, et al. . Prevalence and impact of diabetes and cardiovascular disease on clinical outcome among patients with COVID-19 in Bangladesh. Diabetes Metab Syndr: Clin Res Rev. (2021) 15:1009&#x2013;16. 10.1016/j.dsx.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8106201</ArticleId><ArticleId IdType="pubmed">33993046</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. . Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:811&#x2013;2. 10.1001/jamacardio.2020.1017</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1017</ArticleId><ArticleId IdType="pmc">PMC7101506</ArticleId><ArticleId IdType="pubmed">32219356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications. (2020) 34:107637. 10.1016/j.jdiacomp.2020.107637</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107637</ArticleId><ArticleId IdType="pmc">PMC7242955</ArticleId><ArticleId IdType="pubmed">32456846</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Opu RR, Ahmed SN, Sarkar MK, Jaheen R, Daullah MU, et al. . Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: a nationwide study amid the second wave. Diabetes Metab Syndr: Clin Res Rev. (2021) 15:102148. 10.1016/j.dsx.2021.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.021</ArticleId><ArticleId IdType="pmc">PMC8236060</ArticleId><ArticleId IdType="pubmed">34186349</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (nCoV) Infection is Suspected. Available online at: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratoryinfection (accessed April 20, 2023).</Citation></Reference><Reference><Citation>Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in COVID-19. N Engl J Med. (2020) 382:e102. 10.1056/NEJMoa2007621</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2007621</ArticleId><ArticleId IdType="pmc">PMC7206931</ArticleId><ArticleId IdType="pubmed">32356626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A, Schnell O. COVID-19: Considerations of diabetes and cardiovascular disease management. J Diabetes Sci Technol. (2020) 14:723&#x2013;4. 10.1177/1932296820930025</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1932296820930025</ArticleId><ArticleId IdType="pmc">PMC7673148</ArticleId><ArticleId IdType="pubmed">32475168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract. (2020) 162:108132. 10.1016/j.diabres.2020.108132</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108132</ArticleId><ArticleId IdType="pmc">PMC7118535</ArticleId><ArticleId IdType="pubmed">32234504</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. . Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. (2020) 55:5. 10.1183/13993003.01227-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01227-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Dey SK. Impact of population density and weather on COVID-19 pandemic and SARS-CoV-2 mutation frequency in Bangladesh. Epidemiol Infect. (2021) 149:29. 10.1017/S0950268821000029</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000029</ArticleId><ArticleId IdType="pmc">PMC7844183</ArticleId><ArticleId IdType="pubmed">33407987</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif N, Sarkar MK, Ahmed SN, Ferdous RN, Nobel NU, Parvez AK, et al. . Environmental correlation and epidemiologic analysis of COVID-19 pandemic in ten regions in five continents. Heliyon. (2021) 7:e06576. 10.1016/j.heliyon.2021.e06576</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2021.e06576</ArticleId><ArticleId IdType="pmc">PMC7998049</ArticleId><ArticleId IdType="pubmed">33817387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2020) 395:1054&#x2013;62. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. . Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. (2020) 2:1069&#x2013;76. 10.1007/s42399-020-00363-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00363-4</ArticleId><ArticleId IdType="pmc">PMC7314621</ArticleId><ArticleId IdType="pubmed">32838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with covid-19: Evidence from meta-analysis. Aging. (2020) 12:6049&#x2013;57. 10.18632/aging.103000</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103000</ArticleId><ArticleId IdType="pmc">PMC7185114</ArticleId><ArticleId IdType="pubmed">32267833</ArticleId></ArticleIdList></Reference><Reference><Citation>Imam Z, Odish F, Gill I, O'Connor D, Armstrong J, Vanood A, et al. . Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. J Intern Med. (2020) 288:469&#x2013;76. 10.1111/joim.13119</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13119</ArticleId><ArticleId IdType="pmc">PMC7300881</ArticleId><ArticleId IdType="pubmed">32498135</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas M, Rahaman S, Biswas TK, Haque Z, Ibrahim B. Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis. Intervirology. (2021) 64:36&#x2013;47. 10.1159/000512592</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512592</ArticleId><ArticleId IdType="pmc">PMC7801974</ArticleId><ArticleId IdType="pubmed">33296901</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye C, Zhang S, Zhang X, Cai H, Gu J, Lian J, et al. . Impact of comorbidities on patients with COVID-19: a large retrospective study in Zhejiang, China. J Med Virol. (2020) 92:2821&#x2013;9. 10.1002/jmv.26183</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26183</ArticleId><ArticleId IdType="pmc">PMC7323387</ArticleId><ArticleId IdType="pubmed">32543710</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. (2020) 8:e21. 10.1016/S2213-2600(20)30116-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30116-8</ArticleId><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>